Save time and get answers to complex questions with AI chat
Mebendazole ingredients?Campath litigation germany?When will generic fiasap insulin be available?Guselkumab patent expiration?Bortezomib market france?
See the DrugPatentWatch profile for Atomoxetine
What type of medication is Atomoxetine? Atomoxetine is a non-stimulant medication classified as a norepinephrine reuptake inhibitor (NRI) [1]. It works by increasing the levels of norepinephrine in the brain, a neurotransmitter that helps regulate attention and impulse control. How does Atomoxetine differ from stimulants? Unlike traditional stimulant medications used to treat attention deficit hyperactivity disorder (ADHD), such as amphetamine or methylphenidate, Atomoxetine does not stimulate the brain in the same way [2]. Instead, it targets the norepinephrine system to produce its therapeutic effects. Why is Atomoxetine useful in treating ADHD? Atomoxetine has been shown to be effective in reducing symptoms of attention deficit hyperactivity disorder (ADHD) in both children and adults, including improvements in attention, impulse control, and hyperactivity [3]. Is Atomoxetine suitable for all patients with ADHD? No, Atomoxetine may not be appropriate for everyone with ADHD. Patients with certain medical conditions, such as glaucoma, tachyarrhythmias, or heart failure, should use Atomoxetine with caution or avoid it altogether [4]. What are the possible side effects of Atomoxetine? Common side effects of Atomoxetine include nausea, vomiting, fatigue, and dizziness. Less common side effects may include headaches, irritability, and changes in appetite or sleep patterns [5]. References [1] DrugPatentWatch.com. (n.d.). Atomoxetine. Retrieved from https://www.drugpatentwatch.com/atomoxetine/ [2] FDA. (2020). Strattera (atomoxetine) Tablets [ Package Insert]. Retrieved from https://www.accessdata.fda.gov/drugsatfdadocs/label/2020/021113s031lbl.pdf [3] Viggiano, D. et al. (2006). Efficacy and safety of atomoxetine in attention-deficit/hyperactivity disorder. Expert Review of Neurotherapeutics, 6(10), 1429-1441. [4] FDA. (2020). Strattera (atomoxetine) Tablets [ Package Insert]. Retrieved from https://www.accessdata.fda.gov/drugsatfdadocs/label/2020/021113s031lbl.pdf [5] DrugPatentWatch.com. (n.d.). Atomoxetine. Retrieved from https://www.drugpatentwatch.com/atomoxetine/
Other Questions About Atomoxetine :